A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease

View/ Open
Author
Menche, Jörg
Sharma, Amitabh
Mayer, Ruth J
Rennard, Stephen I
Miller, Bruce E
Locantore, Nick
Tal-Singer, Ruth
Ghosh, Soumitra
Larminie, Chris
Bradley, Glyn
Riley, John H
Agusti, Alvar
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/1752-0509-8-S2-S8Metadata
Show full item recordCitation
Menche, J., A. Sharma, M. H. Cho, R. J. Mayer, S. I. Rennard, B. Celli, B. E. Miller, et al. 2014. “A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease.” BMC Systems Biology 8 (Suppl 2): S8. doi:10.1186/1752-0509-8-S2-S8. http://dx.doi.org/10.1186/1752-0509-8-S2-S8.Abstract
Background: An important step toward understanding the biological mechanisms underlying a complex disease is a refined understanding of its clinical heterogeneity. Relating clinical and molecular differences may allow us to define more specific subtypes of patients that respond differently to therapeutic interventions. Results: We developed a novel unbiased method called diVIsive Shuffling Approach (VIStA) that identifies subgroups of patients by maximizing the difference in their gene expression patterns. We tested our algorithm on 140 subjects with Chronic Obstructive Pulmonary Disease (COPD) and found four distinct, biologically and clinically meaningful combinations of clinical characteristics that are associated with large gene expression differences. The dominant characteristic in these combinations was the severity of airflow limitation. Other frequently identified measures included emphysema, fibrinogen levels, phlegm, BMI and age. A pathway analysis of the differentially expressed genes in the identified subtypes suggests that VIStA is capable of capturing specific molecular signatures within in each group. Conclusions: The introduced methodology allowed us to identify combinations of clinical characteristics that correspond to clear gene expression differences. The resulting subtypes for COPD contribute to a better understanding of its heterogeneity.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101699/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:12717534
Collections
- HMS Scholarly Articles [18129]
Contact administrator regarding this item (to report mistakes or request changes)